Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Color and Odor Assessment in Intermediates – V 2.0

Posted on By

API Manufacturing: SOP for Color and Odor Assessment in Intermediates – V 2.0

Standard Operating Procedure for Color and Odor Assessment in Intermediates in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/086/2025
Supersedes SOP/API/086/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a procedure for the visual and olfactory assessment of color and odor in API intermediates to ensure product consistency and detect abnormal process variations during manufacturing.

2. Scope

This SOP applies to all intermediate materials produced during the synthesis of Active Pharmaceutical Ingredients (APIs) where color and odor are specified as in-process

quality checks.

3. Responsibilities

  • Production Chemist: Perform initial observation and record any deviations in the Batch Manufacturing Record (BMR).
  • QC Analyst: Confirm and document the observations in laboratory logs and compare with reference standards.
  • QA Officer: Review recorded observations and manage deviations or investigations if required.
See also  API Manufacturing: SOP for Sampling Frequency and Quantity Guidelines - V 2.0

4. Accountability

Production Head is accountable for proper in-process monitoring. QC Head is responsible for ensuring accuracy and compliance in documentation.

5. Procedure

5.1 Sample Collection

  1. Collect ~5–10 g of the intermediate in a clean, dry glass container immediately after the relevant process step (e.g., filtration, drying, or crystallization).
  2. Ensure the sample is representative by sampling from multiple locations if applicable.
  3. Label the container with Product Name, Batch No., Sampling Stage, Date, and Time.

5.2 Color Assessment

  1. Place the sample against a white background under daylight equivalent light (D65 or 6000–6500 K).
  2. Compare color visually with standard/reference material or documented appearance in BMR.
  3. Describe color using standard terminology (e.g., off-white, pale yellow, brownish grey).
  4. If deviation is observed, document using “Color and Odor Deviation Form” (Annexure-1) and notify QA.
See also  API Manufacturing: SOP for Blending of Final Dried API - V 2.0

5.3 Odor Assessment

  1. Carefully waft vapor from the sample towards the nose without direct inhalation.
  2. Use a clean fume hood if required for hazardous materials.
  3. Compare odor with process expectations (e.g., sulfur-like, solvent odor, acidic, aromatic, odorless).
  4. Note intensity (e.g., mild, strong, pungent) and any unusual smells that may indicate impurity or degradation.

5.4 Acceptance Criteria

  1. Color and odor must match the specification or range mentioned in the Master Formula Record (MFR) or analytical method.
  2. Deviations must be evaluated through additional analytical testing (e.g., HPLC, GC) if needed.
  3. QA shall assess impact on product quality and decide on batch disposition.

5.5 Documentation and Records

  1. Enter observations in the Batch Manufacturing Record and QC worksheet.
  2. Attach reference color photograph or comparator (if available) for traceability.
  3. Maintain all forms and logs as per documentation SOP.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • API: Active Pharmaceutical Ingredient
  • BMR: Batch Manufacturing Record
  • MFR: Master Formula Record
  • QC: Quality Control
  • QA: Quality Assurance
See also  API Manufacturing: SOP for Handling of Exothermic Reactions - V 2.0

7. Documents

  1. Color and Odor Deviation Form (Annexure-1)
  2. Batch Manufacturing Record
  3. Reference Color Comparator (if applicable)

8. References

  • ICH Q8 – Pharmaceutical Development
  • 21 CFR Part 211 – US FDA cGMP
  • Internal Visual Inspection and Sensory Evaluation SOP

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Color and Odor Deviation Form

Date Batch No. Sampling Stage Observed Color Observed Odor Expected Appearance Remarks
13/04/2025 API-20250413 Post-Crystallization Off-white Mild solvent odor White, odorless Referred to QA

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release New Visual Check Requirement QA Head
13/04/2025 2.0 Added Odor Intensity and Comparator Reference Section Process Standardization QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: Qualification of Method Development Instruments – V 2.0
Next Post: Creams: SOP for Packaging Integrity Testing of Cream Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version